{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:27:27Z","timestamp":1787959647876,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.contraception.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T18:07:38Z","timestamp":1468951658000},"page":"650-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review"],"prefix":"10.1016","volume":"94","author":[{"given":"Erin N.","family":"Berry-Bibee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine B.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halley E.M.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Pamela","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.07.011_bb0005","series-title":"Mental health statistics","author":"National Institutes of Mental Health","year":"2015"},{"key":"10.1016\/j.contraception.2016.07.011_bb0010","doi-asserted-by":"crossref","first-page":"542.e1","DOI":"10.1016\/j.ajog.2010.07.007","article-title":"Mental health and access to services among US women of reproductive age","volume":"203","author":"Farr","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0015","series-title":"Practice guidelines for the treatment of patients with major depressive disorder","author":"Association","year":"2010"},{"key":"10.1016\/j.contraception.2016.07.011_bb0020","series-title":"Practice guidelines for the treatment of patients with panic disorder","author":"Association","year":"2009"},{"key":"10.1016\/j.contraception.2016.07.011_bb0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.contraception.2016.07.011_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(98)00024-9","article-title":"Depressive symptoms and depo-Provera","volume":"57","author":"Westhoff","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.011_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jadohealth.2013.02.009","article-title":"Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods","volume":"53","author":"Hall","year":"2013","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2016.07.011_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.socscimed.2013.10.037","article-title":"The risk of unintended pregnancy among young women with mental health symptoms","volume":"100","author":"Hall","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.contraception.2016.07.011_bb0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2012.03.012","article-title":"Fatal flaws in a recent meta-analysis on abortion and mental health","volume":"86","author":"Steinberg","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ajog.2005.02.103","article-title":"The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration","volume":"193","author":"Halbreich","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14767050701209560","article-title":"Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature","volume":"20","author":"Alder","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.contraception.2016.07.011_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.earlhumdev.2010.04.004","article-title":"Anxiety disorders before birth and self-perceived distress during pregnancy: associations with maternal depression and obstetric, neonatal and early childhood outcomes","volume":"86","author":"Martini","year":"2010","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.contraception.2016.07.011_bb0065","series-title":"Drug interaction studies \u2014study design, data analysis, Implicationsfor dosing, and labeling recommendations","article-title":"Guidance for industry","author":"Administration. USDoHaHSFaD","year":"2012"},{"key":"10.1016\/j.contraception.2016.07.011_bb0070","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.07.011_bb0075","author":"U.S. Preventative Services Task Force"},{"key":"10.1016\/j.contraception.2016.07.011_bb0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1067\/mob.2002.124939","article-title":"Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy","volume":"187","author":"Koke","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jwh.2012.3479","article-title":"Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the sequenced treatment alternatives to relieve depression (STAR*D) study","volume":"22","author":"Kornstein","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2016.07.011_bb0090","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00007691-200112000-00011","article-title":"Enantioselective analysis of citalopram and metabolites in adolescents","volume":"23","author":"Carlsson","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.contraception.2016.07.011_bb0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/FTD.0b013e31815b3f62","article-title":"Therapeutic drug monitoring of escitalopram in an outpatient setting","volume":"29","author":"Reis","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.contraception.2016.07.011_bb0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00004714-200208000-00012","article-title":"Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting","volume":"22","author":"Reis","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40261-013-0117-6","article-title":"Pharmacokinetic drug interactions involving vortioxetine (Lu AA21004), a multimodal antidepressant","volume":"33","author":"Chen","year":"2013","journal-title":"Clin Drug Investig"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2016.07.011_bb0110","first-page":"76","article-title":"Clomipramine and oral contraceptives: an interaction study--clinical findings","volume":"8","author":"Gringras","year":"1980","journal-title":"J Int Med Res"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2016.07.011_bb0115","first-page":"88","article-title":"Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing","volume":"8","author":"John","year":"1980","journal-title":"J Int Med Res"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2016.07.011_bb0120","first-page":"96","article-title":"Relating plasma levels of clomipramine and clinical response","volume":"8","author":"Seldrup","year":"1980","journal-title":"J Int Med Res"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.07.011_bb0125","first-page":"99","article-title":"Influence of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine","volume":"56","author":"Luscombe","year":"1980","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.contraception.2016.07.011_bb0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0009-9236(03)00202-9","article-title":"Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation","volume":"74","author":"Palovaara","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2016.07.011_bb0135","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1046\/j.1365-2125.2000.00153.x","article-title":"Ziprasidone and the pharmacokinetics of a combined oral contraceptive","volume":"49","author":"Muirhead","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.2010.03880.x","article-title":"The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine","volume":"71","author":"Haslemo","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/dmdi-2014-0005","article-title":"Lurasidone drug\u2013drug interaction studies: a comprehensive review","volume":"29","author":"Chiu","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1016\/j.contraception.2016.07.011_bb0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.1983.85","article-title":"Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives","volume":"33","author":"Abernethy","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.07.011_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1985.218","article-title":"Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction","volume":"38","author":"Kroboth","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.07.011_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.1840030219","article-title":"Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines","volume":"3","author":"Patwardhan","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.contraception.2016.07.011_bb0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/j.1552-4604.1988.tb05759.x","article-title":"Alprazolam pharmacokinetics in women on low-dose oral contraceptives","volume":"28","author":"Scavone","year":"1988","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0170","first-page":"37","article-title":"Interaction between certain psychopharmaca and low-dose oral contraceptives","volume":"38","author":"Somos","year":"1990","journal-title":"Ther Hung"},{"key":"10.1016\/j.contraception.2016.07.011_bb0175","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.1984.240","article-title":"Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics","volume":"36","author":"Stoehr","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.07.011_bb0180","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/030006057300100543","article-title":"Drug interactions with clomipramine (Anafranil)","volume":"1","author":"Beaumont","year":"1973","journal-title":"J Int Med Res"},{"key":"10.1016\/j.contraception.2016.07.011_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0009-8981(87)90161-6","article-title":"Therapeutic drug monitoring of amitriptyline: impact of age, smoking and contraceptives on drug and metabolite levels in bulimic women","volume":"165","author":"Edelbroek","year":"1987","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.contraception.2016.07.011_bb0190","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/clpt.1984.114","article-title":"Imipramine disposition in users of oral contraceptive steroids","volume":"35","author":"Abernethy","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2016.07.011_bb0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004714-200212000-00013","article-title":"Clozapine and oral contraceptives: a possible drug interaction","volume":"22","author":"Gabbay","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/JCP.0000000000000074","article-title":"Oral contraceptives raise plasma clozapine concentrations","volume":"34","author":"Bookholt","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.contraception.2016.07.011_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1176\/appi.psy.48.2.170","article-title":"Clozapine case series","volume":"48","author":"Sandson","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.contraception.2016.07.011_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13256-015-0547-2","article-title":"Clozapine toxicity due to a multiple drug interaction: a case report","volume":"9","author":"Cadeddu","year":"2015","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.contraception.2016.07.011_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4088\/JCP.13m08443","article-title":"National trends in long-term use of antidepressant medications: results from the U.S. National Health and nutrition examination survey","volume":"75","author":"Mojtabai","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.contraception.2016.07.011_bb0220","first-page":"1","article-title":"Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since","volume":"2012","author":"Jones","year":"1995","journal-title":"Natl Health Stat Rep"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T09:21:05Z","timestamp":1656840065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416301652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0010782416301652"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}